Intellectual Property | chemanager-online.com - Chemistry and Life Science

Jul. 15, 2019
News & Opinions
Umicore Expands Metathesis Chemistry and Cross-coupling Catalysis Portfolio
Umicore‘s business unit Precious Metals Chemistry has signed an agreement with Evonik to take over the German specialty chemicals company’s intellectual property in the field of metathesis chemistry and cross-coupling ...
Dec. 06, 2017
News & Opinions
Celanese Sues Polish Sweetener Distributor
US specialty materials company Celanese is suing Polish distributor Falken Trade Polska over alleged infringement of its patent on sweetener acesulfame potassium, or Ace-K. The lawsuit, filed in Poland, alleges that the Olsztyn-based firm ...
Aug. 25, 2016
News & Opinions
Metabolix Sells Biopolymer Assets to CJ CheilJedang
Just one month after announcing it was quitting the biopolymers business, Metabolix has signed a binding letter of intent (LOI) to sell its assets to South Korean food company CJ CheilJedang (CJ). For $10 million, CJ gets the US ...
Jun. 24, 2016
News & Opinions
Invista Celebrates Another China Infringement Win
US nylon producer Invista has won another intellectual property (IP) arbitration against an undisclosed Chinese company for misusing its proprietary PTA technology. Invista said the result was encouraging and continued its track record of ...
Apr. 05, 2016
Topics
Supplier-Customer Relationship
Chemical companies both large and small are more comfortable today than ever before with outsourced contract manufacturing, or tolling, as it’s commonly called. For many tolling is a first resort unless they have a proprietary ...
Apr. 04, 2016
Topics
The New Globalism
In September of 2015, Siegfried completed all closing conditions for its acquisition of the custom synthesis business of BASF and parts of the German group’s active pharmaceutical ingredients (APIs).
Jan. 15, 2016
News & Opinions
BioAmber and Reverdia Sign Non-Assert Pact
Netherlands-based biomaterials producer Reverdia has signed a non-assert agreement with BioAmber of the US with regard to intellectual property rights for bio-succinic acid.
Oct. 08, 2015
Topics
The Biggest Side-Effect of Making Medicine
International intellectual property regulations are doing serious damage to the pharmaceutical industry and, by extension, to the health of people around the world. The core of the problem: growing global concern about how to ensure ...
Aug. 27, 2015
News & Opinions
Lilly Wins Court Ruling on Alimta Patent
A court in Indiana, USA, has ruled in Eli Lilly’s favor in a long-running patent battle with Teva Pharmaceutical Industries relating to infringement of the vitamin regimen for its blockbuster cancer drug Alimta. ...
Jun. 08, 2015
Topics
New Challenges Demand New Processes
Despite their innate conservatism, the chemical, pharmaceutical, oil and gas industries are always looking for new products that are more effective than those they replace, or cheaper, more environment-friendly routes to existing products. ...

12 3

Register now!

The latest information directly via newsletter.

GIT Verlag